PVALB and Alpers syndrome: Quantification revealed a significant loss of parvalbumin+ interneurons within the occipital cortex of patients with Alpers' syndrome relative to controls and SUDEP patients (P < 0.001, Figure 2) including a severe loss in 8 of 10 patients (z < −4).